Mode
Text Size
Log in / Sign up

Cross-Sectional Analysis of Cardiac Structure and Function in 57 Adults With Sickle Cell Disease

Cross-Sectional Analysis of Cardiac Structure and Function in 57 Adults With Sickle Cell Disease
Photo by Tim Cooper / Unsplash
Key Takeaway
Consider transthoracic echo for risk stratification in SCD, noting observational design limits causal inference.

This observational, cross-sectional study evaluated cardiovascular profiles in 57 adults (≥18 years) with confirmed Sickle Cell Disease. Conducted at a tertiary referral centre in Cali, Colombia, the research screened 669 individuals to include the final sample.

Demographics included a median age of 24 years (IQR 21-32), with 59.6% female participants and 76.4% possessing the SS genotype. Hydroxyurea use was reported in 71.4% of the cohort. Echocardiographic data showed a median haemoglobin of 10.2 g/dL (IQR 9.3-11.4) and median NT-proBNP of 491 pg/mL (IQR 98-1290). Left ventricular ejection fraction was 63% (IQR 57-66.5), while mean global longitudinal strain was -18.9% (+/- 2.9).

Regarding cardiac geometry, 42.1% had normal LV geometry, 24.6% concentric remodelling, 21.1% concentric hypertrophy, and 12.3% eccentric hypertrophy. Diastolic function was normal in 71.4% of patients. Pulmonary hypertension probability markers included TR velocity >2.5 m/s in 29.8% and TR velocity >3.0 m/s in 10.5%. Mean TAPSE was 25.4 mm (+/- 4.6).

The authors explicitly state that the observational design limits causal inference. Follow-up duration was not reported, and adverse events were not reported. Despite these constraints, the practice relevance supports routine use of transthoracic echocardiography as an accessible tool for early cardiovascular risk stratification in adults with SCD in low- and middle-income settings. Clinicians should interpret these findings as associations rather than definitive outcomes.

Study Details

Study typeSystematic review
Sample sizen = 669
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
Sickle cell disease (SCD) is associated with substantial cardiovascular morbidity, but echocardiographic data from Latin American populations remain scarce. We aimed to characterise the structural, functional, and haemodynamic echocardiographic profile of adults with SCD attending a tertiary referral centre in Cali, Colombia. We conducted an observational, cross-sectional study based on systematic review of medical records and transthoracic echocardiography reports of consecutive adult patients ([≥]18 years) with confirmed SCD evaluated between January 2022 and December 2024. Patients with complex congenital heart disease, severe valvular disease of unrelated aetiology, pregnancy, or echocardiograms of insufficient quality were excluded. Of 669 patients screened, 57 met inclusion criteria. Reporting followed STROBE recommendations. The median age was 24 years (interquartile range [IQR] 21-32) and 59.6% were female; the SS genotype was the most frequent (76.4%) and 71.4% were on hydroxyurea. Median haemoglobin was 10.2 g/dL (IQR 9.3-11.4) and median NT-proBNP 491 pg/mL (IQR 98-1290). Most patients had preserved left ventricular dimensions and systolic function (median ejection fraction 63%, IQR 57-66.5; mean global longitudinal strain -18.9% {+/-} 2.9). Right ventricular function was preserved (mean tricuspid annular plane systolic excursion 25.4 {+/-} 4.6 mm). Left ventricular geometry was normal in 42.1%, with concentric remodelling in 24.6%, concentric hypertrophy in 21.1%, and eccentric hypertrophy in 12.3%. Diastolic function was normal in 71.4%. Valvular disease, when present, was predominantly mild. Tricuspid regurgitation velocity exceeded 2.5 m/s in 29.8% of patients and exceeded 3.0 m/s in 10.5%, identifying a substantial subgroup at intermediate-to-high probability of pulmonary hypertension. In this Colombian cohort of relatively young adults with SCD, cardiac structure and biventricular function were largely preserved, but nearly one-third of patients had echocardiographic findings suggestive of pulmonary hypertension. These findings support the routine use of transthoracic echocardiography as an accessible tool for early cardiovascular risk stratification in adults with SCD in low- and middle-income settings.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.